Tribal Advisory Committee (TAC) Meeting — September 2020

Tuesday, September 15, 2020
Schedule Presentation Presenter
2:00 p.m. Roll Call and Welcome

Kendra King Bowes
Project Manager
Miami Environmental & Energy Solutions (MEES)

2:05 p.m.

TAC Acting Chair Updates

Lisa Sundberg
TAC Acting Chair

2:10 p.m.

Discussion on Tribal participation in COVID-19 vaccine trials

  • Current platforms used in vaccine clinical trials
  • Tribal interest in vaccine clinical trials
  • Data sharing and clinical trial participation
  • Community engagement needs

Dave Wilson, Ph.D.
Director, THRO

James M. Anderson, M.D., Ph.D.
NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives, OD

TAC Members

Guest:
Devin Delrow, J.D.
Associate Director for Tribal Affairs, Office of the Secretary, | Intergovernmental and External Affairs, HHS

2:25 p.m. THRO Updates
  • STAC meeting - NIAID & THRO presentation
  • Congressional Interest in Clinical Trial Diversity
  • Tribal Health Data Improvement Act

Dave Wilson, Ph.D.
Director, THRO

Donna Crews, M.S.W.
Legislative Analyst, NIH Office of Legislative Policy and Analysis

2:35 p.m.

Discussion on How the TAC Moves Forward

  • Agendas - How can we more effectively set monthly agendas? How can Delegates proactively engage with TAC Chair around agenda setting? 
  • Moderating Discussions - How do we ensure all Delegates have a chance to speak and share time fairly during the meeting?
  • Fall TAC Meeting - How should we plan for a Fall meeting which would be virtual? Length? Dates? Theme?
  • Delegate Caucusing - How can we handle and plan for caucusing?
  • Working Groups - What is the status of working group activities?
  • Role of TAC
    • Are we fulfilling our role in advising NIH on policies, programs, and priorities?
    • How do we do this during the pandemic?
    • What are the critical questions we should be asking ourselves to fulfill our role?
    • What activities and issues are high priority?
    • In terms of COVID-19, what needs to be done now with respect to research/trials, and what can we start planning for?
    • What type of community engagement or education needs to be done around clinical trials and around anticipation of a vaccine?
  • Accessing NIH Materials and Information
    • Would delegates be interested in a secure NIH site where they could access materials?
    • Are delegates familiar with the THRO website? Do you use it? What’s needed? 
  • Materials for TAC Delegates to Disseminate
    • What kind of materials do Delegates need to share with their communities about NIH, research and TAC activities?
    • Would one-pagers on topics of interest be helpful? (e.g. explaining CoVPN; explaining the THRO AI/AN grant finder, etc.)

Lisa Sundberg
TAC Acting Chair

TAC Members

3:25 p.m.

Next Steps and Action Items

  • Do Delegates have requests for agenda items to be discussed at next month’s meeting?

Lisa Sundberg
TAC Acting Chair

3:30 p.m. Adjourn Meeting  

This page last reviewed on March 24, 2021